#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic granulomatosis with polyangiitis Leiomyosarcoma metastatic Immunodeficiency Glomerulonephritis chronic B-cell small lymphocytic lymphoma Sexually transmitted disease Exudative retinopathy Multifocal motor neuropathy Hyperadrenocorticism Biotinidase deficiency Cystic fibrosis respiratory infection suppression Systemic lupus erythematosus Adult T-cell lymphoma/leukaemia refractory Hormone-dependent prostate cancer Neuromyelitis optica spectrum disorder More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Trials in Disease Breast angiosarcoma – Life with Disease Antithrombin III deficiency – Treatment Niemann-Pick disease – Life with Disease Leiomyosarcoma – Trials in Disease Bronchopulmonary dysplasia – Basic Information Factor IX deficiency – Life with Disease Adrenocortical carcinoma – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Hepatic angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anv600 Donepezil Inotuzumab Ozogamicin Doxazosin Quercetin Jnj-77242113 Mva-209-Fsp-B3 Paltusotine Efmoroctocog Alfa [18F]Alf-Nota-Octreotide Imsidolimab Vinorelbine Quinidine Sulfate Fluticasone Nefopam Hydrochloride Etravirine Ribonucleic Acid K10 AGALSIDASE BETA Abrocitinib ALKYLATING AGENTS More therapies…

    Learn about Your Condition

    Shprintzen-Goldberg syndrome Naevoid melanoma Hypopituitarism Malignant glioma Atopic keratoconjunctivitis Mixed-type liposarcoma Bladder cancer stage II Psychological trauma Meningococcal infection Pancreaticoduodenectomy Streptococcal infection Glioblastoma Carpal tunnel syndrome Orthostatic hypotension Lymphatic malformation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Androgenetic alopecia
    Investigated Drugs:
    • Clascoterone
    Germany Poland

  • Study on the Effects and Safety of Povorcitinib for Adults with Chronic Spontaneous Urticaria

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Povorcitinib
    Germany Poland

  • Study on the Effectiveness and Safety of Deucravacitinib for Adults with Chronic Hand Eczema

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hand dermatitis
    Investigated Drugs:
    • Deucravacitinib
    Germany

  • Study on Izokibep for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Izokibep
    France Germany Hungary Poland Spain

  • Study on the Effectiveness and Safety of Tirbanibulin Ointment for Adults with Actinic Keratosis on the Face or Scalp

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tirbanibulin
    Germany Italy The Netherlands Poland Spain

  • Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Desoximetasone
    • Folic Acid
    • Methotrexate
    Czechia France Italy Poland
Previous Page
1 … 54 55 56 57 58 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!